In a research report sent to investors today, Oppenheimer analyst Ling Wang reiterated an Outperform rating on Rockwell Medical (NASDAQ:RMTI) with a $26 price …
In a research report sent to investors today, Brean Capital analyst Jonathan Aschoff reiterated a Sell rating on Rockwell Medical (NASDAQ:RMTI) with a …
Oppenheimer analyst Ling Wang initiated Outperform rating on Rockwell Medical (NASDAQ:RMTI) with a $24 price target, which represents a potential upside of 152% …
